frequent urination semaglutide Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Semaglutide Side Effects Week by

Your results will depend on factors like your starting weight, commitment to a healthy lifestyle, and consistency with your treatment plan

(NEJM 2023) CagriSema: Superior glycemic & weight outcomes vs semaglutide alone

That leaves 9mg potentially beyond its safe use date

Further a 1-point lower score on the PCS and PF, RP, BP, GH, VT, and SF scales were associated with a 2% to 4% increase in risk of hospitalization over the following 6 months, a 7% to 12% increase in being unable to work, and a 4% to 7% increase in losing the ability to work over the following 6 months

About the study Researchers conducted a retrospective cohort study using de-identified electronic health records from the TriNetX United States Collaborative Network between January 2020 and November 2025